Ep. 64: Telemedicine in China in the time of COVID-19: Part 2

Tech Buzz China by Pandaily

Το περιεχόμενο παρέχεται από το SupChina. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον SupChina ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

4+ y ago 38:23

MP3•Αρχική οθόνη επεισοδίου

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 15, 2021 22:04 (3y ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Episode 64 of Tech Buzz China is the second of two episodes on the Chinese telemedicine sector, which is closely watched in the wake of COVID-19. This week, on the heels of episode 63’s discussion of Ping An Good Doctor, co-hosts Rui Ma and Ying-Ying Lu talk about other experiments, such as Chunyu Yisheng 春雨医生, WeDoctor 好大夫, and Dingxiangyuan 丁香园. We also give overviews of telemedicine efforts by some of the large internet companies, including Alibaba, Baidu, and JD Health.

The overarching story is that healthcare tech is a clear market opportunity in China, and within the narrow space of telemedicine, there are a lot of companies trying to solve the same set of problems. Listen to find out: How did these players all converge on telemedicine, and what are the factors — some currently missing — that must be in place to drive a serious uptick in adoption?

You can find these stories and more at pandaily.com. If you enjoy our content, please do let us know by leaving us an iTunes review, and tweeting at us at @techbuzzchina. We also read your emails, at rui@techbuzzchina.com and ying@techbuzzchina.com. You can also subscribe to our Extra Buzz newsletter on our new website, techbuzzchina.com. As always, thank you for your support.

We are grateful for our talented producers, Caiwei Chen and Kaiser Kuo. Stay healthy, everyone!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

84 επεισόδια

#Tech #Business News #News #Tech News #China #SupChina #Nio #China Tech #Alibaba #Bytedance #Community Group Buying